{"name":"Wu Jiang","slug":"wu-jiang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"20μg Kangtai hepatitis B vaccine","genericName":"20μg Kangtai hepatitis B vaccine","slug":"20-g-kangtai-hepatitis-b-vaccine","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"20μg Kangtai hepatitis B vaccine","genericName":"20μg Kangtai hepatitis B vaccine","slug":"20-g-kangtai-hepatitis-b-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOSVBINkNXVDYtd05ybFRQR2hObDgwR1FWQU96Uk1NNDlGcmJqWm1SOHRZQ0I3MktnUGlqeXkyRlg4TFpfMzBWb2VKUTd3YnJjUkVpWFY0eXNUZGZLY0NQbXh3bVV5NG82V1QyN0xpNEIxTVREZnNfTVJYdGNBY2tSRmlVelQyLUh1QjVlZEREQVFZR09TdkxoWA?oc=5","date":"2026-01-28","type":"trial","source":"Endpoints News","summary":"Can a Chinese drugmaker become a big pharma company? Hengrui is testing the waters - Endpoints News","headline":"Can a Chinese drugmaker become a big pharma company? Hengrui is testing the waters","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPQzVpT01GOUxEM3hmaEUwOExzcXVwREYweVZxSWdMNTQxekV0VnNVZjlLMmtrUVBsNVpJaktvWVdxVzAyNFoxcmtReXl3RWN1SzBWY09oOGZYRnNBMXhRVUpHcUhwdXhFUDdCaGNBSy1jR1V3NmhkMThZNUJNQzYtZDBueVdvRC1uUXlhQTE0M0JOT0t0MkI2aHBhczhidXJHSXQybGM1YlBXT0xpMkNV?oc=5","date":"2025-08-21","type":"pipeline","source":"research.arizona.edu","summary":"Repackaged cancer drug boosts delivery to tumors, improves combination therapies - research.arizona.edu","headline":"Repackaged cancer drug boosts delivery to tumors, improves combination therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9Pa0lnbEFRb19nUl9MYlg4WUppQ002dlU1c2xpeWlMUUJPeGs2UXVQM0tnQUNZZUd6aHp2VG4wRUV0N0Q1R1J3RkFHUnMzd2RBU2JSVWtEeF9SSjYtcjJ3?oc=5","date":"2025-07-04","type":"trial","source":"Nature","summary":"Understanding the gap between expectations and reality in decentralized clinical trials - Nature","headline":"Understanding the gap between expectations and reality in decentralized clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBkSW94QVVyaVZOV1YyODlGUVA1QnR0clJhaTNJSF9MRVFteXcwMFVZMHA2MXlMclo1ZUJIQUtoV3dqazRWVU5oWEIzdVhaMUttN2tCZ3dDeko1bkxZNkRIMDBqUjJGaGFKdHJuMWVhZzM?oc=5","date":"2025-06-10","type":"pipeline","source":"Wiley Online Library","summary":"Supramolecular Host–Guest Assemblies for Tunable and Modular Lysosome-Targeting Protein Degradation - Wiley Online Library","headline":"Supramolecular Host–Guest Assemblies for Tunable and Modular Lysosome-Targeting Protein Degradation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE5qejFRYkJLb3l5aVBVelNlbGVlQlcwUU5fZDFnQ1E2NEJaZjR0dXhvVjNick8wM2ZzN0VSY0RLLUU2aTdxcndaS1kzdjY0dw?oc=5","date":"2025-05-23","type":"pipeline","source":"The Macau Post Daily","summary":"Kiang Wu Hospital launches ‘TCM Orthopaedics & Traumatology Inheritance Programme’ - The Macau Post Daily","headline":"Kiang Wu Hospital launches ‘TCM Orthopaedics & Traumatology Inheritance Programme’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPVFZmT3MzeDhXSGRMeWt5ZlRUNGxJRXhKVFB6XzdrRl9MUEFrYUd6bkE5QnkxUl8tQ3ZkN2d3b3R1RVZndzE3RGdTNUpvNXBTT2xzak9VOW1SUFJOOUUtWVI4anU2Zk9nWGZOVFNfc05nSldwd2VPRHhVYjVfUjl0Y3JxVzRLU3NlaFVobDBqN1VZWkExb2hyRVJWV0ZJLVE?oc=5","date":"2025-04-11","type":"pipeline","source":"RNZ","summary":"How three Chinese families survived NZ's Covid lockdowns - RNZ","headline":"How three Chinese families survived NZ's Covid lockdowns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPaXdEWmk2OW95QzlnWGxZamNKS0xiYVdCcUhxZl9kV2xoYk5fYktFQ2dVLXlTcl9MM3F1NjU4T1FTRHFaTkdnamR5c1o4LUp6bDR1MnRhaE5fQXdPWmNKWVR6blNzdk5IQkMtMk92MGFzMzRlZTlTZTlXNDBaYzY2WVc5RTktSkhqaGp2b205MWpLMk5HUXhSYmFfR0xCZXM?oc=5","date":"2024-10-28","type":"pipeline","source":"Cleanroom Technology","summary":"Wujiang Deshengxin Purification Equipment launches anti-static Fan Filter Unit - Cleanroom Technology","headline":"Wujiang Deshengxin Purification Equipment launches anti-static Fan Filter Unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5rZHBUVUdheHFibDlHV2wyMjNtalNvbjJIc2JsQnhQb1JYSHpSSFNsaWhvMnY2SUFCMXRRZm9JYTJ0eWo2cnI1djBQdEV2bUJyeFdTSW9LQ19Ia3JuRzFR?oc=5","date":"2024-05-10","type":"trial","source":"Nature","summary":"Pharmaceutical treatment status of patients with COPD in the community based on medical Internet of Things: a real-world study - Nature","headline":"Pharmaceutical treatment status of patients with COPD in the community based on medical Internet of Things: a real-world","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOYVlucUV5VkM2TVQtX3RZMk0tM2VJM1Rwc19RZDVGZVhadzVjVU13bVhZanhaaDUzckx3UTd5Q0l1a3hUeXZ3UTZuWDUxQWZXT0thVGhjZnN0QjhrN0UtZ3M1ckVlMW9HSVNWTVFhbVNZNGZKRnVTVWdTYVRGZFR1cnRzUmF2UEV4TVRhWHdwcVNuejk0?oc=5","date":"2024-02-14","type":"pipeline","source":"Frontiers","summary":"Pharmacist-led iodinated contrast media infusion risk assessment service - Frontiers","headline":"Pharmacist-led iodinated contrast media infusion risk assessment service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBhMmZjZjJmYlhER1doZzI4MmFGQ2lUQm81ZlhnRFdDT19mcFBIZzR1UXpodnBweGJGWl9vZnRDNnA2VDZ2dHRNRXRBcUNuRkF6ZDNqY0JETmRwUE1nSWFQa0F5TkVRYjFyTXlnMzU5YjRXNmhPVHRrc241ZTA?oc=5","date":"2023-01-01","type":"pipeline","source":"Xinhua","summary":"Pharma companies speed up anti-epidemic medicine production - Xinhua","headline":"Pharma companies speed up anti-epidemic medicine production","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE10TUF2REFNOGNRaUJEZTRsc3RlakpxS3BSaEFQQ2lxWGpuNi1zTmtjNEloZ0Q0OUFaalpVd2hFWk5yUkp0cXNyN21EVGJMQmNudndrZzNB?oc=5","date":"2018-12-05","type":"pipeline","source":"Market.us","summary":"N-propanol Market Size, Share | CAGR of 5% - Market.us","headline":"N-propanol Market Size, Share | CAGR of 5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNcG05QjlIdEhTS2Jrcm5aRGRHM2pNaDhhRUY3RFFyZjM1QzRHRWRNSWdvWDJaT09jbUtjZmZrLVlRdkpTay1FczFTUnZ5RU1KcjZwN192UGt5d2o0R2NwS1R0eTRaaFRDSnF5VlBQLWVWSnVnQkk1SVh2Q01kTC0zR3hqR0NFMk9XcUJiNHIyRXdpNUhtWmltSVppdVp6UQ?oc=5","date":"2018-05-31","type":"pipeline","source":"Fierce Pharma","summary":"Meet the Gardasil billionaires, spawned from Merck vaccine's advance into China market - Fierce Pharma","headline":"Meet the Gardasil billionaires, spawned from Merck vaccine's advance into China market","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}